silver sulfadiazine (Silvadene, SSD, SSD AF, Thermazene) (cont.)

Pharmacy Author:
Medical and Pharmacy Editor:

PREGNANCY: Use of topical silver sulfadiazine has not been adequately evaluated in pregnant women. Due to the lack of conclusive safety data, silver sulfadiazine should be used in pregnancy only if the potential benefit justifies the potential risk to the fetus. Silver sulfadiazine is classified as FDA pregnancy risk category B (animal reproduction studies have failed to demonstrate a risk to the fetus and there are no adequate and well-controlled studies in pregnant women).

NURSING MOTHERS: It is not known if silver sulfadiazine is excreted in breast milk. However, silver sulfadiazine is a sulfonamide and oral sulfonamides are excreted into breast milk and increase the risk of kernicterus, a rare type of brain damage in newborns caused by very high levels of bilirubin. Therefore, use of silver sulfadiazine in females who are breastfeeding is not recommended.

REFERENCE: FDA Prescribing Information.

Medically Reviewed by a Doctor on 2/4/2015

Report Problems to the Food and Drug Administration

You are encouraged to report negative side effects of prescription drugs to the FDA. Visit the FDA MedWatch website or call 1-800-FDA-1088.

Pill Finder Tool

Need help identifying pills and medications?
Use the pill identifier tool on RxList.

Back to Medications Index